Schedule 13G ownership disclosure
PharmaCyte Biotech, Inc.
Security class unavailable · CUSIP: 17512X203
Event date: 2021-08-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,246,245
- Percent of class
- 6.1200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-21-000094
- Form type
- SC 13G
- Filer
- PharmaCyte Biotech, Inc.
- CIK
- CIK 1157075
- Filed
- Aug 30, 2021
- Reporting period
- Aug 27, 2021
- Description
- Schedule 13G beneficial ownership